• 1. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 4. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 5. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735

Introduction to 4-(3,4-dimethoxyphenyl)-1,3-thiazol-2-amine (CAS No. 51837-85-5)

4-(3,4-dimethoxyphenyl)-1,3-thiazol-2-amine, identified by the Chemical Abstracts Service Number (CAS No.) 51837-85-5, is a significant compound in the field of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic amine derivative features a thiazole core substituted with a 3,4-dimethoxyphenyl group, making it a structurally intriguing molecule with potential applications in medicinal chemistry and drug discovery. The presence of both aromatic and heterocyclic moieties enhances its versatility, enabling diverse chemical modifications and biological interactions.

The compound's molecular structure consists of a five-membered thiazole ring fused with an amine functional group at the 2-position and an aromatic ring at the 4-position. The 3,4-dimethoxyphenyl substituent introduces electron-donating methoxy groups, which can influence the electronic properties and reactivity of the molecule. This structural motif is particularly relevant in the design of bioactive molecules due to its ability to engage in hydrogen bonding, π-stacking interactions, and other non-covalent interactions with biological targets.

In recent years, there has been growing interest in thiazole derivatives as pharmacophores due to their broad spectrum of biological activities. Thiazole scaffolds are well-documented for their roles in antimicrobial, anti-inflammatory, antiviral, and anticancer applications. The specific substitution pattern of 4-(3,4-dimethoxyphenyl)-1,3-thiazol-2-amine positions it as a promising candidate for further exploration in these therapeutic areas.

One of the most compelling aspects of this compound is its potential as a precursor for more complex drug candidates. The thiazole ring can serve as a core structure that can be further functionalized to enhance binding affinity or modulate pharmacokinetic properties. For instance, derivatives of this compound have been investigated for their interactions with enzymes and receptors involved in metabolic diseases and cancer pathways. The 3,4-dimethoxyphenyl group provides a handle for selective modifications, allowing chemists to fine-tune the molecule's properties for specific biological outcomes.

Recent studies have highlighted the importance of aromatic heterocycles in drug design, particularly due to their ability to mimic natural product scaffolds that exhibit strong biological activity. 4-(3,4-dimethoxyphenyl)-1,3-thiazol-2-amine aligns with this trend by combining a well-established heterocyclic system with an aromatic moiety that can enhance solubility and bioavailability. This combination makes it an attractive scaffold for developing novel therapeutics that can overcome common challenges such as poor membrane permeability or rapid metabolic degradation.

The synthesis of 4-(3,4-dimethoxyphenyl)-1,3-thiazol-2-amine typically involves multi-step organic transformations starting from commercially available precursors. Key steps often include condensation reactions to form the thiazole ring followed by selective substitution at the 4-position with the 3,4-dimethoxyphenyl group. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making this compound more accessible for research purposes.

In terms of biological evaluation, preliminary studies suggest that derivatives of this compound may exhibit inhibitory activity against certain enzymes implicated in disease pathways. For example, modifications at the amine position could lead to compounds with kinase inhibition properties relevant to cancer therapy. Similarly, structural analogs might interfere with bacterial enzymes involved in metabolic pathways used by pathogens. These findings underscore the need for systematic investigation into the pharmacological potential of this scaffold.

The role of computational chemistry has also become increasingly important in evaluating the suitability of compounds like 4-(3,4-dimethoxyphenyl)-1,3-thiazol-2-amine for drug development. Molecular modeling techniques can predict binding affinities to target proteins and simulate interactions within biological systems. Such predictions guide experimental efforts by identifying promising derivatives before costly synthesis and testing campaigns begin.

Another area of interest is the exploration of stereochemical aspects associated with this compound. The presence of chiral centers or stereogenic axes can significantly impact biological activity due to differences in enantiomeric binding interactions. Research into stereoselective synthesis or resolution methods could unlock new therapeutic opportunities by optimizing the pharmacological profile based on stereochemical purity.

The environmental impact and sustainability considerations are also gaining traction in pharmaceutical research. Efficient synthetic routes that minimize waste or utilize renewable feedstocks are becoming preferred approaches for developing new compounds like 4-(3,4-dimethoxyphenyl)-1,3-thiazol-2-amine. Green chemistry principles are being integrated into synthetic strategies to ensure that future drug development is both effective and environmentally responsible.

In conclusion,4-(3,4-dimethoxyphenyl)-1,3-thiazol-2-amine (CAS No. 51837-85-5) represents a structurally interesting molecule with significant potential in pharmaceutical research and drug discovery. Its unique combination of a thiazole core and a 3,4-dimethoxyphenyl substituent makes it a versatile scaffold for designing bioactive molecules targeting various disease pathways. Continued investigation into its synthetic possibilities and biological activities will likely yield valuable insights into new therapeutic strategies.

• 105512-82-1(4-(4-phenoxyphenyl)-1,3-thiazol-2-amine)
• 114196-86-0(2-Thiazolamine,4-(4-methoxyphenyl)-, hydriodide (1:1))
• 83558-37-6(4-(3-methoxyphenyl)-1,3-thiazol-2-amine)
• 306935-51-3(4-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-1,3-thiazol-2-amine)
• 111317-60-3(2-Thiazolamine, 4-(4-methoxyphenyl)-, monohydrobromide)
• 185613-91-6(4-(2H-1,3-benzodioxol-5-yl)-1,3-thiazol-2-amine)
• 2104-04-3(4-(4-methoxyphenyl)-1,3-thiazol-2-amine)
• 105362-06-9(4-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,3-thiazol-2-amine)
• 15386-52-4(4-(2-amino-1,3-thiazol-4-yl)benzene-1,2-diol)
• 886495-47-2(4-(3,4-Dimethoxyphenyl)-2-hydrazinylthiazole)